Adicet Bio Inc (ACET)

06:04 AM

JMP maintains Market Perform on Adicet Bio shares By Investing.com - Investing.com India

06:04 AM

Apr 19, 2025

Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World

Apr 19, 2025

Apr 17, 2025

Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada

Apr 17, 2025

Apr 17, 2025

Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace

Apr 17, 2025

Apr 17, 2025

Adicet Bio appoints Michael Grissinger to its board - Investing.com

Apr 17, 2025

Apr 17, 2025

Adicet Bio Appoints Michael Grissinger to Board - TipRanks

Apr 17, 2025

Apr 17, 2025

Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan

Apr 17, 2025

Apr 13, 2025

Norges Bank Acquires Shares of 429,550 Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Apr 13, 2025

Apr 11, 2025

Adicet Bio faces potential Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

Adicet Bio faces potential Nasdaq delisting over share price - Investing.com

Apr 11, 2025

Apr 02, 2025

Virtu Financial LLC Purchases New Stake in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Apr 02, 2025

Apr 01, 2025

Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference - BioSpace

Apr 01, 2025

Mar 31, 2025

Adicet Bio Strengthens Team with Strategic Stock Options Package for Key New Hires - Stock Titan

Mar 31, 2025

Mar 31, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Consensus Target Price from Brokerages - Defense World

Mar 31, 2025

Mar 25, 2025

The Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi and ACET ($ACT) Drive Blockchain Payment Innovation in UAE’s $3.9 Billion USD Initiative - GlobeNewswire Inc.

Mar 25, 2025

Mar 24, 2025

Adicet Bio (NASDAQ:ACET) Earns “Buy” Rating from Guggenheim - The AM Reporter

Mar 24, 2025

Mar 23, 2025

Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey

Mar 23, 2025

Mar 23, 2025

Guggenheim Reiterates Buy Rating for Adicet Bio (NASDAQ:ACET) - Defense World

Mar 23, 2025

Mar 22, 2025

10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey

Mar 22, 2025

Mar 21, 2025

ACET Stock Dips to 52-Week Low at $0.74 Amid Market Challenges - Investing.com

Mar 21, 2025

Mar 18, 2025

Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 16.9% - Defense World

Mar 18, 2025

Mar 17, 2025

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 17, 2025

Mar 12, 2025

Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com Canada

Mar 12, 2025

Mar 12, 2025

Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Adicet Bio (ACET) Expected to Announce Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 10, 2025

Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio - TipRanks

Mar 10, 2025

Mar 09, 2025

Adicet Bio (NASDAQ:ACET) Earns “Neutral” Rating from HC Wainwright - Defense World

Mar 09, 2025

Mar 07, 2025

Adicet Bio Advances Clinical Trials and Financial Stability - TipRanks

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains Neutral on Adicet Bio stock By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains Neutral on Adicet Bio stock - Investing.com India

Mar 07, 2025

Mar 07, 2025

Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes - TipRanks

Mar 07, 2025

Mar 07, 2025

Adicet Bio: Hold Rating Amid Fair Valuation and Awaited Clinical Data - TipRanks

Mar 07, 2025

Mar 06, 2025

Adicet Bio Inc Files For Mixed Shelf Of Up To $250 Million -March 06, 2025 at 04:59 pm EST - Marketscreener.com

Mar 06, 2025

Mar 06, 2025

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress - Lelezard

Mar 06, 2025

Mar 06, 2025

Adicet Bio, Inc Q4 Loss Decreases - Nasdaq

Mar 06, 2025

Mar 06, 2025

Adicet Bio reports Q4 EPS (32c), consensus (35c) - TipRanks

Mar 06, 2025

Mar 06, 2025

Can Adicet Bio's $176M War Chest and Fast Track Status Transform Autoimmune Treatment? - StockTitan

Mar 06, 2025

Mar 06, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Average Target Price from Analysts - Defense World

Mar 06, 2025

Mar 05, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World

Mar 05, 2025